AbbVie woes Shire into $54 billion acquisition deal

U.S. drug maker AbbVie Inc. reaches a deal to buy Shire for about $54 billion, one of the largest deals to date where a U.S. company seeks to lower its tax rate by buying a foreign rival.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.